For YY1, EP300 and ZMYM3, this analysis revealed an increase of mRNA levels in AD cases compared to controls, suggesting that these two systems are comparable for these genes and therefore justifying utilization of whole tissue for further analyses. This evidence concerns the gene ZMYM3 and Alzheimer disease.